Rabeximod
- Generic Name
- Rabeximod
- Drug Type
- Small Molecule
- Chemical Formula
- C22H24ClN5O
- CAS Number
- 872178-65-9
- Unique Ingredient Identifier
- J4D3K58W3Z
Overview
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Background
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Indication
Investigated for use/treatment in rheumatoid arthritis.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath